Page last updated: 2024-10-23

buflomedil and Diseases, Peripheral Vascular

buflomedil has been researched along with Diseases, Peripheral Vascular in 5 studies

buflomedil: RN given refers to parent cpd; synonym LL 1656 refers to HCl; structure

Research Excerpts

ExcerptRelevanceReference
" We performed an international, multicenter, randomized, double-blind, placebo-controlled trial to investigate whether long-term administration of oral buflomedil could reduce the rate of cardiovascular events in patients with intermittent claudication."5.13Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study. ( Becker, F; Leizorovicz, A, 2008)
"Patients with type 2 diabetes mellitus have an increased vascular risk and a series of modifiable risk factors play a crucial role in the atherosclerotic process."2.45Buflomedil: potential new indications for an old agent. ( Hatzitolios, AI; Papadimitriou, DK; Tsantilas, D; Tziomalos, K, 2009)
"Food and Drug Administration for the treatment of intermittent claudication, several supplements and investigational agents have been evaluated."2.45Pharmacologic therapy for intermittent claudication. ( Dobesh, PP; Persson, EL; Stacy, ZA, 2009)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Backer, TL1
Vander Stichele, RH1
Van Bortel, LM1
Tsantilas, D1
Hatzitolios, AI1
Tziomalos, K1
Papadimitriou, DK1
Dobesh, PP1
Stacy, ZA1
Persson, EL1
Leizorovicz, A1
Becker, F1
Conte, MS1

Reviews

2 reviews available for buflomedil and Diseases, Peripheral Vascular

ArticleYear
Buflomedil: potential new indications for an old agent.
    International angiology : a journal of the International Union of Angiology, 2009, Volume: 28, Issue:3

    Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Peripheral Vascular Diseases; Pyrrolidines

2009
Pharmacologic therapy for intermittent claudication.
    Pharmacotherapy, 2009, Volume: 29, Issue:5

    Topics: Cilostazol; Clinical Trials as Topic; Dietary Supplements; Drugs, Investigational; Exercise Therapy;

2009

Trials

2 trials available for buflomedil and Diseases, Peripheral Vascular

ArticleYear
Letter by De Backer et al regarding article, "Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study".
    Circulation, 2008, Sep-02, Volume: 118, Issue:10

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Disease Progr

2008
Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Circulation, 2008, Feb-12, Volume: 117, Issue:6

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Disease Progr

2008

Other Studies

1 other study available for buflomedil and Diseases, Peripheral Vascular

ArticleYear
Buflomedil in peripheral arterial disease: trials and tribulations.
    Circulation, 2008, Feb-12, Volume: 117, Issue:6

    Topics: Adrenergic alpha-Antagonists; Cardiovascular Diseases; Disease Progression; Humans; Intermittent Cla

2008